Cumulative incidence of cardiovascular events after HCT. Cumulative incidence of cardiovascular events after HCT by number of CVRFs (A), by number of CVRFs and pre-HCT cardiotoxic exposure (B), by autologous HCT survivors with pre-HCT cardiotoxic exposure (C), and by allogeneic HCT survivors with pre-HCT cardiotoxic exposure (D). Cardiotox, anthracycline or chest radiation.